Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Foster

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Pharmacoeconomics|March 21, 2000
Abciximab. A pharmacoeconomic review of its use in percutaneous coronary revascularisationC J Dunn, R H Foster
Pharmacoeconomics|March 21, 2000
Acamprosate. Pharmacoeconomic implications of therapyR H Foster, K J McClellan
Drugs & Aging|May 13, 1999
Diclofenac/hyaluronic acidD C Peters, R H Foster
Drugs|September 24, 1999
Deferiprone: a review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseasesJ A Barman Balfour, R H Foster
General Pharmacology|October 29, 1998
Is ouabain produced by the adrenal gland?R H Foster, H Prat, I Rothman
Pharmacoeconomics|September 8, 2000
Mirtazapine. A pharmacoeconomic review of its use in depressionK J Holm, B Jarvis, R H Foster
Pharmacoeconomics|December 8, 1997
Cefotaxime. A pharmacoeconomic review of its use in the treatment of infectionsG L Plosker, R H Foster, P Benfield
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Mycophenolate mofetil: a review of its use in the management of solid organ transplantationA Bardsley-Elliot, S Noble, R H Foster
Drugs|August 1, 1997
Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillationR H Foster, M I Wilde, A Markham
Drugs|May 20, 1998
TazaroteneR H Foster, R N Brogden, P Benfield
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Pharmacoeconomics|March 21, 2000
Abciximab. A pharmacoeconomic review of its use in percutaneous coronary revascularisationC J Dunn, R H Foster
Pharmacoeconomics|March 21, 2000
Acamprosate. Pharmacoeconomic implications of therapyR H Foster, K J McClellan
Drugs & Aging|May 13, 1999
Diclofenac/hyaluronic acidD C Peters, R H Foster
Drugs|September 24, 1999
Deferiprone: a review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseasesJ A Barman Balfour, R H Foster
General Pharmacology|October 29, 1998
Is ouabain produced by the adrenal gland?R H Foster, H Prat, I Rothman
Pharmacoeconomics|September 8, 2000
Mirtazapine. A pharmacoeconomic review of its use in depressionK J Holm, B Jarvis, R H Foster
Pharmacoeconomics|December 8, 1997
Cefotaxime. A pharmacoeconomic review of its use in the treatment of infectionsG L Plosker, R H Foster, P Benfield
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Mycophenolate mofetil: a review of its use in the management of solid organ transplantationA Bardsley-Elliot, S Noble, R H Foster
Drugs|August 1, 1997
Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillationR H Foster, M I Wilde, A Markham
Drugs|May 20, 1998
TazaroteneR H Foster, R N Brogden, P Benfield
Pageof 4